Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report

By www.reliableresearchiq.com

Report Details

Report Name

Global And United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Report & Forecast 2023-2028 Story

Pages

92

Price

$ 4350

Features

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Astellas Inc.
Johnson & Johnson
Sanofi S.A
Dendreon Corporation
Bayer AG